Translator Disclaimer
1 October 2012 Sufentanil Citrate Immobilization of Alaskan Moose Calves
Author Affiliations +
Abstract

Free-ranging Alaskan moose calves (Alces alces gigas) were immobilized with 0.12 mg/kg sufentanil (S; n=16), 0.12 mg/kg sufentanil plus 0.27 mg/kg xylazine (SX; n=11), or 0.007 mg/kg carfentanil plus 0.36 mg/kg xylazine (CX; n=13). Immobilants were antagonized with 1.2 mg/kg naltrexone (S) or 1.2 mg/kg naltrexone plus 2.4 mg/kg tolazoline (SX, CX). There were no differences in induction (P≥0.29) or processing (P≥0.44) times between groups. Moose given either S or SX had significantly shorter recovery times than moose given CX (P=0.001) and recovery times from S were shorter than from SX (P=0.02). Oxygen saturation values for all groups averaged 85±8%, but were significantly higher (P=0.048) for CX (89±7%) than for S (82±8%). Based on these data, sufentanil at 0.1 mg/kg or sufentanil at 0.1 mg/kg plus xylazine at 0.25 mg/kg could provide effective remote immobilization for Alaskan moose calves and could be substituted for carfentanil or thiafentanil should the need arise.

Terry J. Kreeger and Kalin A. Kellie "Sufentanil Citrate Immobilization of Alaskan Moose Calves," Journal of Wildlife Diseases 48(4), (1 October 2012). https://doi.org/10.7589/2012-04-112
Received: 19 April 2012; Accepted: 1 May 2012; Published: 1 October 2012
JOURNAL ARTICLE
4 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top